openPR Logo
Press release

Migraine KOL Interview

08-08-2017 08:39 AM CET | Health & Medicine

Press release from: ReportsWorldwide

ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports.

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access

February 08, 2017

We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic and chronic migraine. The drugs discussed include the anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody AMG 334 (AMGN), anti-CGRP monoclonal antibodies ALD403 (ALDR), LY2951742 (LLY) and TEV-48125 (TEVA), small molecule CGRP receptor antagonists atogepant (AGN), ubrogepant (AGN) and telcagepant (MRK), small molecule 5HT1F receptor agonist lasmiditan (CLCD), Botox (AGN), triptans Imitrex (GSK), Maxalt (MRK) and Topamax (JNJ), Treximet (PTX), Atacand (AZN) and TI-001.

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41334

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Migraine KOL Interview here

News-ID: 658653 • Views: 285

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for CGRP

Migraine Drugs Market to Perceive Substantial Growth During 2014-2025: Key Playe …
The migraine is a major issue related to headache described by intermittent headaches which are moderate to severe. Basically, the headaches influence one portion of the head, are throbbing in nature, and may last in between two to 72 hours. The related indications may incorporate vomiting, sensitivity, and nausea to smell, light, or sound. The torment is for the most part exacerbated by physical activity. Up to 33% of individuals
Wearable wireless Patch Device Market 18% CGRP to 2023: Global Market Analysis, …
A wearable wireless healthcare patch is an all-in-one monitor that can measure heart rate, breathing patterns and other vital signs, offering both clinical and consumer healthcare uses. The Wearable wireless Patch Device Market to grow at a CAGR of +18% during the Forecast period. Wearable Medical Devices have grown phenomenally over the years in terms of their usage. Request Sample Copy of this report: http://qyreports.com/request-sample?report-id=101421 Top Key Vendors: Fitbit, Garmin, Jawbone, Lifewatch, Misfit, Monica
Global Migraine Market 2018 Key Players: Eli Lilly & Company, Teva Pharmaceutica …
Migraine Market: WiseGuyReports.com adds “Migraine Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database. Executive Summary FDA has recently approved first ever novel migraine preventive drug that resorts to prevention rather than treatment. It is posed as a breakthrough drug with immense market potential in upcoming years. The report “Global Migraine Market (By Nations-The US, the UK, Germany, France, Italy, Spain and Japan; Drugs- Triptan, CGRP,
In-Depth Analysis of Calcitonin Gene Related Peptide (CGRP) Pipeline and Therape …
Market Research Hub (MRH) has included a new extensive and fact-based research publication, titled "Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2018" in its extensive research database. This study examines comprehensive information on the therapeutics under development for Calcitonin Gene Related Peptide, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Moreover, its pipeline analysis by companies
Global Market Report on Calcitonin Gene Related Peptide (CGRP)-Pipeline Review, …
"The Report Calcitonin Gene Related Peptide (CGRP)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Calcitonin Gene Related Peptide (CGRP)-Calcitonin gene related peptide (CGRP) is a member of the calcitonin family of peptides. It exists in two forms alpha-CGRP and beta-CGRP. CGRP is produced in both peripheral and central neurons. CGRP is derived mainly from the cell bodies of
Huntingtin (Huntington Disease Protein or HTT) Therapeutic Landscape and Pipelin …
Market Research Hub (MRH) has included a new research report titled “Huntingtin (Huntington Disease Protein or HTT) Pipeline Review H2 2017”, outlays comprehensive information on the Calcitonin Gene Related Peptide (CGRP) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Calcitonin Gene Related Peptide (CGRP) targeted therapeutics development with respective active